Fri, March 23, 2018
Thu, March 22, 2018
Wed, March 21, 2018
Tue, March 20, 2018
Mon, March 19, 2018
Fri, March 16, 2018
Thu, March 15, 2018
Wed, March 14, 2018
Tue, March 13, 2018
Mon, March 12, 2018
Fri, March 9, 2018
Thu, March 8, 2018
Wed, March 7, 2018
Tue, March 6, 2018
Mon, March 5, 2018
Fri, March 2, 2018

David Nierengarten Maintained (SYRS) at Buy with Increased Target to $130 on, Mar 13th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-130-on-mar-13th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
David Nierengarten of Wedbush, Maintained "Syros Pharmaceuticals, Inc." (SYRS) at Buy with Increased Target from $110 to $130 on, Mar 13th, 2018.

David, nor any peers, have made any analyst calls on SYRS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30